Stromal disrupting effects of nab-paclitaxel in pancreatic cancer-Reference-Cited by-同舟云学术

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

Published:2013-08 Issue:4 Volume:109 Page:926-933
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Alvarez R,Musteanu M,Garcia-Garcia E,Lopez-Casas P P,Megias D,Guerra C,Muñoz M,Quijano Y,Cubillo A,Rodriguez-Pascual J,Plaza C,de Vicente E,Prados S,Tabernero S,Barbacid M,Lopez-Rios F,Hidalgo M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2013415.pdf

Reference19 articles.

1. Andriulli A, Festa V, Botteri E, Valvano MR, Koch M, Bassi C, Maisonneuve P, Sebastiano PD (2012) Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Ann Surg Oncol 19: 1644–1662.

2. Arnold SA, Rivera LB, Miller AF, Carbon JG, Dineen SP, Xie Y, Castrillon DH, Sage EH, Puolakkainen P, Bradshaw AD, Brekken RA (2010) Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma. Dis Model Mech 3: 57–72.

3. Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP (2011) Significance of pathologic response to preoperative therapy in pancreatic cancer. Ann Surg Oncol 18: 3601–3607.

4. Dawwas MF, Taha H, Leeds JS, Nayar MK, Oppong KW (2012) Diagnostic accuracy of quantitative EUS elastography for discriminating malignant from benign solid pancreatic masses: a prospective, single-center study. Gastrointest Endosc 76 (5): 953–961.

5. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S, Mooney M, Rubinstein L, Shankar L, Dodd L, Kaplan R, Lacombe D, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45: 228–247.

Cited by 248 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Left out in the cold: Moving beyond hormonal therapy for the treatment of immunologically cold prostate cancer with CAR T cell immunotherapies;The Journal of Steroid Biochemistry and Molecular Biology;2024-10

2. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis;Drug Resistance Updates;2024-09

3. A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers;International Journal of Molecular Sciences;2024-06-15

4. CAR-T Cell Therapy in Pancreatic and Biliary Tract Cancers: An Updated Review of Clinical Trials;Journal of Gastrointestinal Cancer;2024-05-02

5. Navigating tumor angiogenesis: therapeutic perspectives and myeloid cell regulation mechanism;Angiogenesis;2024-04-06